Taipei, Taiwan

Yung-Leun Shih

This inventor holds 1 USPTO granted patent. Top assignee: Taipei Medical University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yung-Leun Shih. Retrieved from https://idiyas.com/inventor/yung-leun-shih

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yung-Leun Shih: Innovator in Medical Diagnostics

Introduction

Yung-Leun Shih is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the development of antibodies for the diagnosis and treatment of diseases associated with α-enolase I.

Latest Patents

Yung-Leun Shih holds a patent titled "Anti-α-enolase I antibodies for diagnosis and treatment of α-enolase I-associated diseases." This invention relates to antibodies against α-enolase I, including their pharmaceutical compositions and diagnostic uses. The patent specifically provides polyclonal anti-α-enolase I antibodies and monoclonal single-chain variable fragment (scFv) anti-α-enolase antibodies. These innovations have potential applications in the diagnosis and treatment of cancers, autoimmune disorders, ischemia, and bacterial infections. He has 1 patent to his name.

Career Highlights

Yung-Leun Shih is affiliated with Taipei Medical University, where he continues to advance research in the medical field. His work has garnered attention for its potential impact on improving diagnostic methods and therapeutic strategies.

Collaborations

He has collaborated with notable colleagues, including Sy-Jye Leu and Yi-Yuan Yang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yung-Leun Shih's contributions to medical diagnostics through his innovative patent on α-enolase I antibodies highlight his role as a key figure in the field. His work continues to pave the way for advancements in the diagnosis and treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…